Clearside Biomedical informa las ganancias trimestralmente. Estos informes de ganancias trimestrales ofrecen a los inversores una visión de los resultados financieros de una empresa durante un período de 3 meses. Los informes de ganancias casi siempre incluyen resultados de EPS e ingresos.
Analice el historial de beneficios de Clearside Biomedical utilizando filtros y clasificaciones avanzadas.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
CLSD | Clearside Biomedical | -$0.10 | -$0.07 | — | — | $1.04M | $312.86K | — | — | 11/11/2025 | |
CLSD | Clearside Biomedical | -$0.10 | -$0.07 | -$0.06 | 0.00% | $90.00K | $170.00K | $492.00K | 213.78% | 08/08/2025 | |
CLSD | Clearside Biomedical | -$0.17 | -$0.10 | -$0.11 | 0.00% | $230.00K | $170.00K | $2.33M | 1077.78% | 05/14/2025 | |
CLSD | Clearside Biomedical | -$0.08 | -$0.11 | -$0.10 | 0.00% | $6.34M | $170.00K | $306.00K | 3.93% | 03/27/2025 | |
CLSD | Clearside Biomedical | -$0.15 | -$0.12 | -$0.10 | 23.08% | $859.00K | $122.86K | $1.04M | 744.88% | 11/12/2024 | |
CLSD | Clearside Biomedical | -$0.15 | -$0.13 | -$0.10 | 23.08% | $1.02M | $152.00K | $90.00K | -40.00% | 08/12/2024 | |
CLSD | Clearside Biomedical | -$0.15 | -$0.14 | -$0.17 | -21.43% | $4.00K | $580.00K | $230.00K | -60.34% | 05/09/2024 | |
CLSD | Clearside Biomedical | -$0.16 | -$0.09 | -$0.08 | 11.11% | $330.00K | $4.43M | $6.34M | 43.23% | 03/12/2024 | |
CLSD | Clearside Biomedical | -$0.13 | -$0.15 | -$0.15 | 0.00% | $266.00K | $160.00K | $859.00K | 436.88% | 11/13/2023 | |
CLSD | Clearside Biomedical | -$0.13 | -$0.14 | -$0.15 | -7.14% | $384.00K | $120.00K | $1.02M | 748.33% | 08/14/2023 | |
CLSD | Clearside Biomedical | -$0.13 | -$0.14 | -$0.15 | -7.14% | $347.00K | $140.00K | $4.00K | -97.14% | 05/11/2023 | |
CLSD | Clearside Biomedical | $0.31 | -$0.13 | -$0.16 | -23.08% | $25.69M | $100.00K | $330.00K | 230.00% | 03/09/2023 | |
CLSD | Clearside Biomedical | -$0.08 | -$0.03 | -$0.13 | -333.33% | $3.07M | $6.52M | $266.00K | -95.92% | 11/09/2022 | |
CLSD | Clearside Biomedical | -$0.11 | -$0.13 | -$0.13 | 0.00% | $780.00K | $370.00K | $384.00K | 3.78% | 08/09/2022 | |
CLSD | Clearside Biomedical | -$0.13 | -$0.08 | -$0.13 | -62.50% | $34.00K | $2.87M | $347.00K | -87.91% | 05/11/2022 | |
CLSD | Clearside Biomedical | -$0.14 | $0.16 | $0.31 | 93.75% | $11.00K | $17.77M | $25.69M | 44.55% | 03/10/2022 | |
CLSD | Clearside Biomedical | -$0.05 | -$0.08 | -$0.08 | 0.00% | $3.43M | $2.58M | $3.07M | 19.15% | 11/10/2021 | |
CLSD | Clearside Biomedical | -$0.13 | -$0.12 | -$0.11 | 8.33% | $354.00K | $690.00K | $780.00K | 13.04% | 08/10/2021 | |
CLSD | Clearside Biomedical | -$0.07 | -$0.10 | -$0.13 | -30.00% | $4.10M | $2.12M | $34.00K | -98.40% | 05/17/2021 | |
CLSD | Clearside Biomedical | -$0.07 | -$0.11 | -$0.14 | -27.27% | $1.94M | $1.29M | $11.00K | -99.15% | 03/10/2021 | |
CLSD | Clearside Biomedical | -$0.17 | -$0.12 | -$0.05 | 58.33% | $141.00K | $1.82M | $3.43M | 88.57% | 11/10/2020 |
Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
---|---|---|---|---|
Q2 | 2025-08-08 | $-0.06 | $-0.07 | 0.00 % |
Q1 | 2025-05-14 | $-0.11 | $-0.10 | 0.00 % |
Q4 | 2025-03-27 | $-0.10 | $-0.11 | 0.00 % |
Q3 | 2024-11-12 | $-0.10 | $-0.12 | 23.1 % |
Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
---|---|---|---|---|
Q2 | 2025-08-08 | $492.00K | $170.00K | 213.8 % |
Q1 | 2025-05-14 | $2.33M | $170.00K | 1077.8 % |
Q4 | 2025-03-27 | $306.00K | $170.00K | 3.93 % |
Q3 | 2024-11-12 | $1.04M | $122.86K | 744.9 % |
Está previsto que Clearside Biomedical (CLSD) presente resultados el noviembre 11, 2025. Los últimos resultados se publicaron el agosto 8, 2025 para el Q2.
El BPA real fue de $-0.06, que superó la estimación de $-0.07.
Los ingresos reales fueron $492K, que superó la estimación de $170K.
Explora Estimaciones de beneficios, BPA e ingresos sobre todos los valores.